PT Diastika Biotekindo Tbk (ISX:CHEK) Total Liabilities: Rp0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PT Diastika Biotekindo Tbk Total Liabilities?

PT Diastika Biotekindo Tbk ISX:CHEK +1.54% Total Liabilities is Rp0.00 Mil as of . 20. The stock has 1 warning sign investors should review.

PT Diastika Biotekindo Tbk's Total Liabilities for the quarter that ended in . 20 was Rp0.00 Mil.

PT Diastika Biotekindo Tbk Total Liabilities Historical Data

* Premium members only.

The historical data trend for PT Diastika Biotekindo Tbk's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Diastika Biotekindo Tbk Total Liabilities Chart

PT Diastika Biotekindo Tbk Annual Data
Trend
Total Liabilities

PT Diastika Biotekindo Tbk Semi-Annual Data
Total Liabilities

PT Diastika Biotekindo Tbk Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

PT Diastika Biotekindo Tbk's Total Liabilities for the fiscal year that ended in . 20 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=+(+
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+++)
=N/A

Total Liabilities=Total Assets (A: . 20 )-Total Equity (A: . 20 )
=N/A-N/A
=N/A

PT Diastika Biotekindo Tbk's Total Liabilities for the quarter that ended in . 20 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=+(+
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+++)
=N/A

Total Liabilities=Total Assets (Q: . 20 )-Total Equity (Q: . 20 )
=N/A-N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of Rp0.00 Mil mean?
PT Diastika Biotekindo Tbk (ISX:CHEK) has a Total Liabilities of Rp0.00 Mil as of . 20. The total amount of liabilities as recorded on a company's balance sheet. View historical data for PT Diastika Biotekindo Tbk and its competitors.
Is PT Diastika Biotekindo Tbk's Total Liabilities too high?
PT Diastika Biotekindo Tbk's current Total Liabilities is Rp0.00 Mil.
How does PT Diastika Biotekindo Tbk's Total Liabilities compare to ABT and SYK?
PT Diastika Biotekindo Tbk's Total Liabilities of Rp0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for PT Diastika Biotekindo Tbk and its competitors. PT Diastika Biotekindo Tbk's current Total Liabilities is Rp0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Diastika Biotekindo Tbk stock overvalued right now?
PT Diastika Biotekindo Tbk (ISX:CHEK) has a current Total Liabilities of Rp0.00 Mil. The current Total Liabilities is Rp0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For PT Diastika Biotekindo Tbk (ISX:CHEK), the current Total Liabilities is Rp0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Diastika Biotekindo Tbk Business Description

Address Jalan Rawagelam V, Kawasan Industri Pulogadung, Block L, No. Kav 11-13, Gedung Etana Lantai 3, Desa/Kelurahan Jatinegara, Kec. Cakung, Kota Adm. Jakarta Timur, Jakarta, IDN, 13930
PT Diastika Biotekindo Tbk is engaged in providing medical and laboratory equipment solutions in Indonesia. It is engaged in the wholesale trading of laboratory equipment, pharmaceutical products, and medical devices for human use. The company is also involved in wholesale trading of radioactive substances and ionizing radiation generators, and undertakes activities related to the testing and/or calibration of medical devices, as well as the inspection of healthcare facilities and infrastructure. Its product offerings mainly include devices like hematology analyzer, pipette, hemoglobin testing system, etc. The company's operating segments are: Diagnostics Group, which generates the maximum revenue, and Life Sciences Group. Geographically, all of its revenue is derived from Indonesia.